市场调查报告书
商品编码
1380403
2023-2030 年全球持针器市场Global Needle Holders Market 2023-2030 |
全球持针器市场预计在预测期(2023-2030年)CAGR为11.8%。关键因素包括全球外科手术的普及、需要精确仪器控制的微创技术的进步、老年人口的不断增长导致对手术干预的需求更高,以及可提高手术效率的创新持针器设计的不断发展。
全球持针器市场按类型、应用程式和最终用户进行细分。根据类型,市场细分为 Mayo Hegar 持针器、Mathieu 持针器、Castroviejo 持针器、debakey 持针器、derf 持针器、halsey 持针器、heaney 持针器和碳化钨持针器。根据应用,市场细分为牙科、心血管、妇科、眼科、骨科等。此外,其他应用包括腹腔镜和泌尿外科。此外,根据最终用户,市场分为医院和门诊手术中心。在最终用户中,由于门诊手术的显着转变、特定手术的适当专业化、对微创手术的日益关注以及采用技术进步。
其中,心血管细分市场预计将在全球持针器市场中占据相当大的份额。该细分市场的成长归因于全球心血管疾病盛行率的不断上升。据世界卫生组织称,每年约有 1,790 万人死于心血管疾病,占全球死亡人数的 32%。在这些死亡中,85%是由于心臟病发作和中风。因此,这些因素将进一步提高对先进和精确手术工具的需求,预计这将推动市场成长。这些是进行精细手术的重要工具,可以帮助外科医生精确缝合,并有助于减少心血管疾病过早死亡的数量。
全球持针器市场根据地理位置进一步细分,包括北美(美国和加拿大)、欧洲(英国、义大利、西班牙、德国、法国和欧洲其他地区)、亚太地区(印度、中国、日本) 、韩国和亚洲其他地区)以及世界其他地区(中东和非洲以及拉丁美洲)。其中,亚太地区预计将在全球市场中占据显着份额,因为新兴经济体的治疗率、可支配收入的增加和医疗基础设施的改善正在推动亚太地区的持针器市场。
在所有地区中,北美地区预计在预测期内将以相当大的CAGR成长。由于不健康的生活方式导致整容手术等手术数量不断增加,以及生活水平的提高预计将推动该市场的发展,北美市场正在成长。根据美国整形外科医师协会(ASPS) 的数据,2022 年整容手术总数为1,498,361 例,较2019 年的1,255,228 例有所增加。此外,心血管和神经系统疾病等慢性疾病的盛行率正在快速增长,从而加速了北美的手术持针器市场。
美国代谢与减肥外科学会预计,2021 年,2 型糖尿病将成为最常见的糖尿病形式。美国有 3,260 万人患有第 2 型糖尿病。此外,这种疾病会导致许多严重的健康问题,包括心臟病、中风、高血压、肾衰竭、失明、皮肤伤口、神经损伤(神经病变)、勃起功能障碍和认知能力下降等。此类疾病需要手术,预计将推动持针器市场的需求。
Title: Global Needle Holders Market Size, Share & Trends Analysis Report by Type (Mayo Hegar Needle Holder, Mathieu Needle Holder, Castroviejo Needle Holder, Debakey Needle Holder, Derf Needle Holder, Halsey Needle Holder, Heaney Needle Holder, and Tungsten Carbide Needle Holder), by Application (Dental, Cardiovascular, Gynecology, Ophthalmic, Orthopedic and Others), and by End-User (Hospitals and Ambulatory Surgical Centers)Forecast Period (2023-2030).
The global needle holders market is anticipated to grow at a CAGR of 11.8% during the Forecast Period (2023-2030). Pivotal factors such as the rising prevalence of surgical procedures globally, advancements in minimally invasive techniques requiring precise instrument control, the growing geriatric population leading to higher demand for surgical interventions, and the continuous development of innovative needle holder designs that boost surgical efficiency.
The global needle holders market is segmented on the type, application and end user. Based on the type, the market is sub-segmented into mayo hegar needle holder, mathieu needle holder, castroviejo needle holder, debakey needle holder, derf needle holder, halsey needle holder, heaney needle holder, and tungsten carbide needle holder. Based on the application, the market is sub-segmented into dental, cardiovascular, gynecology, ophthalmic, orthopedic and others. Further, the other applications includes laparoscopic, and urology. Further, based on end user, the market is sub-segmented into hospitals and ambulatory surgical centers. Among the end user, the ambulatory surgical centers sub-segment is anticipated to hold a considerable share of the market, owing to the significant shift toward outpatient procedures, proper specialization in specific procedures, the rising focus on minimally invasive procedures, and the adoption of technological advancements.
Among the application, the cardiovascular sub-segment is expected to hold a considerable share of the global needle holders market. The segment growth is attributed to the increasing prevalence of CVDs around the globe. According to the WHO, approximately 17.9 million people die due to CVDs annually, representing 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke. Hence, these factors would further lift the demand for advanced and precise surgical tools, which is projected to surge market growth. These are essential tools for performing delicate surgeries, helping surgeons achieve accurate suturing, and contributing to reducing the number of premature CVD mortality.
The global needle holders market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, Asia pacific is anticipated to hold a prominent share of the market across the globe, owing to the rising treatment rates, the rising disposable income and improving healthcare infrastructure in emerging economies are driving the Needle Holders market in the Asia Pacific.
Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. The North America market is growing owing to factors including the rising number of surgeries including cosmetic surgical procedures due to unhealthy lifestyles, and the growing standard of living is expected to boost the market. According to the American Society of Plastic Surgeons (ASPS), in 2022, total cosmetic surgical procedures were 1,498,361 which increased from 1,255,228 in 2019. Further, rising prevalence of chronic diseases, such as cardiovascular and neurological disorders is growing at a rapid pace thus accelerating the surgical needle holder market in North America.
American Society for Metabolic and Bariatric Surgery, in 2021, type 2 diabetes, the most common form of diabetes. There are 32.6 million people in the US living with type 2 diabetes. Moreover, this disease lead to many serious health problems including heart disease, stroke, high blood pressure, kidney failure, blindness, skin wounds, nerve damage (neuropathy), erectile dysfunction, and cognitive decline among many others. Such diseases required to the surgery which anticipate to propel the demand for needle holders market.
The major companies serving the global needle holders market include: Becton, Dickinson, and Company, Hu-Friedy Mfg. Co., LLC, J & J Instruments, Inc., Olympus Corp., B. Braun of America Inc., Bailey Instruments Ltd, Duckworth & Kent Ltd, H&H Co., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in December 2021, Corza Medical GmbH acquired Katena products and its ophthalmic surgery offerings. Katena develops ophthalmic products used across cataract, glaucoma, and corneal surgeries, including precision surgical instruments, single-use devices, and specialty biologics. The acquisition expanded its surgical product portfolio while adding significant scale, product breadth and infrastructure to its ophthalmic surgery segment.